Category hub · Longevity & cognitive 50+
Bioregulators
Short peptide "bioregulators," many developed from organ-specific extracts in earlier Russian research, proposed to influence gene expression and tissue-specific function. The evidence is largely early-stage and under-replicated, which we flag throughout.
Peptides in this category
16 profilesAdamax
Synthetic peptide (research compound)
Adamax is a little-known synthetic research peptide sometimes grouped with short bioregulators and promoted for possible cognitive effects. Published information is minimal and preliminary, so its effects and safety in people are not established or independently confirmed.
Read profileCardiogen
Peptide bioregulator
Cardiogen is a short synthetic peptide marketed as a bioregulator aimed at the heart and cardiac muscle. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profileCartalax
Peptide bioregulator
Cartalax is a short synthetic peptide marketed as a bioregulator aimed at cartilage and joint tissue. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profileBronchogen
Peptide bioregulator
Bronchogen is a short synthetic peptide marketed as a bioregulator aimed at the lungs and bronchial tissue. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profileCortagen
Peptide bioregulator
Cortagen is a short synthetic peptide marketed as a bioregulator aimed at the brain and nervous system. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profileChonluten
Peptide bioregulator
Chonluten is a short synthetic peptide (three amino acids) marketed as a bioregulator aimed at the lungs and bronchial tissue. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profileDS5
Synthetic peptide (research compound)
DS5 is a little-known synthetic research peptide with very little published information. The available data are minimal and preliminary, so essentially nothing about its effects or safety in people is established or independently confirmed.
Read profileLivagen
Peptide bioregulator
Livagen is a short synthetic peptide marketed as a bioregulator, sometimes described as a relative of Epitalon and aimed at liver and immune function. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profileOvagen
Peptide bioregulator
Ovagen is a short synthetic peptide marketed as a bioregulator aimed at the liver and digestive system. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profilePancragen
Peptide bioregulator
Pancragen is a short synthetic peptide marketed as a bioregulator aimed at the pancreas and blood sugar regulation. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profilePinealon
Peptide bioregulator
Pinealon is a short synthetic peptide (three amino acids) marketed as a bioregulator aimed at the brain and nervous system. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profilePGPIPN
Synthetic hexapeptide
PGPIPN is a short synthetic peptide (six amino acids) derived from a milk protein and studied mainly for possible immune and anti-tumor effects in the laboratory. The supporting research is mostly small and preclinical, so the human evidence is essentially absent and unconfirmed.
Read profileProstamax
Peptide bioregulator
Prostamax is a short synthetic peptide blend marketed as a bioregulator aimed at the prostate and male urinary health. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profileTestagen
Peptide bioregulator
Testagen is a short synthetic peptide marketed as a bioregulator aimed at the male reproductive system. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profileVesugen
Peptide bioregulator
Vesugen is a short synthetic peptide marketed as a bioregulator aimed at blood vessels and the vascular system. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.
Read profileVilon
Peptide bioregulator
Vilon is a very short synthetic peptide (two amino acids) developed by a Russian research group as a so-called bioregulator for the immune system. The supporting research is mostly small, older, and from a single laboratory, so the human evidence is weak and has not been independently confirmed.
Read profile